Page last updated: 2024-09-03

ginsenoside rh2 and Non-alcoholic Fatty Liver Disease

ginsenoside rh2 has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, J; Han, K; Han, M; Liang, P; Liu, S; Lu, H; Yuan, X; Zhang, Y1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Non-alcoholic Fatty Liver Disease

ArticleYear
HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129

    Topics: Animals; Autophagy-Related Proteins; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Ginsenosides; Hep G2 Cells; Humans; Insulin; Interleukin-6; Lipolysis; Liver; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Tumor Necrosis Factor-alpha

2020